Home/Filings/4/0001225208-19-004207
4//SEC Filing

CANGIALOSI LORETTA V 4

Accession 0001225208-19-004207

CIK 0000078003other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 7:29 PM ET

Size

20.1 KB

Accession

0001225208-19-004207

Insider Transaction Report

Form 4
Period: 2019-02-27
CANGIALOSI LORETTA V
Sr. Vice President, Controller
Transactions
  • Award

    Common Stock

    2019-02-28+3,482108,607 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2019-02-2725,7290 total
    Exercise: $32.23From: 2019-02-27Exp: 2019-02-27Common Stock (25,729 underlying)
  • Tax Payment

    Common Stock

    2019-02-27$42.93/sh4,819$206,880121,015 total
  • Award

    Stock Appreciation Rights

    2019-02-28+15,21115,211 total
    Exercise: $43.35From: 2026-02-28Exp: 2026-02-28Common Stock (15,211 underlying)
  • Exercise/Conversion

    Common Stock

    2019-02-27$32.23/sh+25,729$829,246121,743 total
  • Award

    Common Stock

    2019-02-27+8,017129,760 total
  • Tax Payment

    Common Stock

    2019-02-27$42.93/sh3,926$168,543125,834 total
  • Tax Payment

    Common Stock

    2019-02-27$42.31/sh15,890$672,306105,125 total
  • Award

    Stock Appreciation Rights

    2019-02-28+18,05018,050 total
    Exercise: $43.35From: 2024-02-28Exp: 2024-02-28Common Stock (18,050 underlying)
Holdings
  • Common Stock

    (indirect: By Rule 16b-3 Plan)
    2,110
Footnotes (9)
  • [F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F2]The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
  • [F3]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
  • [F4]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
  • [F5]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
  • [F6]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
  • [F7]The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
  • [F8]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
  • [F9]The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.

Documents

1 file

Issuer

PFIZER INC

CIK 0000078003

Entity typeother

Related Parties

1
  • filerCIK 0001174449

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:29 PM ET
Size
20.1 KB